Seattle Genetics Inc. (SGEN) Dividend History

Seattle Genetics Inc is a development-stage biotech company. It develops monoclonal antibody-based therapies. Its lead product, Adcetris, has received approval for relapsed/refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma.

Last update 09/24/2020


Dividend Yield Summary

  2015 2016 2017 2018 2019 2020
Dividends - - - - - -
Average Price 40.66 44.88 58.87 62.09 80.28 139.77
Yield - - - - - -
• The above Dividend, Average Price, and Yield values for 2020 are year-to-date.

Dividend History

No history of dividends
Date Amount Per Share Note